Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.
National Natural Science Foundation of China
Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
Brunger, Adams, Clore, Gros, Nilges and Read
chimeric peptide, lipopolysaccharide, LBP14, Antibacterial activity, Anti-inflammatory activity, N6, ANTIBIOTIC